Not Tagged
Not Tagged
['ibd']
#ddw2023 day 1 had one of the most interesting #ibd studies by i think we may have 2 groups of postop cd: 1. high risk who start &lt;4 wks after surg advanced therapy 2. those who we monitor and treat if recurrence - in this group maybe some never recur? 
Professor & Chair, Digestive Disease and Surgery Institute @ClevelandClinic Gastroenterologist in IBD patient-centered care